MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells
15-Deoxy-Δ12,14-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression
AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib
Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients
Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden
Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer
Pectoral stretching program for women undergoing radiotherapy for breast cancer
Changes in risk of death from breast cancer with season and latitude
Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis
The association between the pre-diagnosis mammography screening interval and advanced breast cancer
Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
Reproductive factors and breast cancer risk among older women
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer